Shared on27 Aug 25
Analysts remain divided on Fluor’s valuation: while some see further upside from its NuScale Power stake and supportive macro trends, others believe the benefits are fully priced in following a sharp share rally, resulting in the consensus analyst price target holding steady at $49.89. Analyst Commentary Bullish analysts see continued upside from Fluor’s valuation linked to its NuScale Power (SMR) stake, with upgraded price targets reflecting revised assessments after deeper analysis of this asset.
Shared on29 Jul 25Fair value Increased 8.03%
Driven by a notable improvement in net profit margin and a sharp decline in future P/E multiple, analysts have significantly increased their fair value estimate for Fluor, raising the consensus price target from $46.18 to $51.94. What's in the News Fluor received final notice to proceed as lead EPCM partner on Barrick's Reko Diq copper-gold project in Pakistan, a multi-decade operation with construction beginning later this year and first production targeted for 2028.
Shared on07 May 25Fair value Decreased 11%
AnalystConsensusTarget has decreased profit margin from 2.8% to 1.1% and increased future PE multiple from 16.6x to 36.7x.
Shared on30 Apr 25Fair value Increased 3.89%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on23 Apr 25Fair value Decreased 1.52%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on17 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on09 Apr 25Fair value Decreased 6.86%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on02 Apr 25Fair value Increased 4.06%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on26 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on19 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on10 Mar 25Fair value Increased 13%
AnalystConsensusTarget has decreased revenue growth from 9.6% to 8.1%.